Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Esaar (India) Ltd
Industry : Finance & Investments
BSE Code
ISIN Demat
Book Value(
)
531502
INE404L01039
15.8140149
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
N.A
50.55
11.37
EPS(TTM)
Face Value(
)
Div & Yield %:
0.11
10
0
Back
Piramal Pharma Ltd
Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter
Oct 24,2024
Net profit of Piramal Pharma rose 350.00% to Rs 22.59 crore in the quarter ended September 2024 as against Rs 5.02 crore during the previous quarter ended September 2023. Sales rose 17.28% to Rs 2241.75 crore in the quarter ended September 2024 as against Rs 1911.38 crore during the previous quarter ended September 2023.
Particulars
Quarter Ended
Sep. 2024
Sep. 2023
% Var.
Sales
2241.75
1911.38
17
OPM %
15.24
13.90
-
PBDT
312.34
224.07
39
PBT
120.12
39.56
204
NP
22.59
5.02
350